[Grounds and perspectives of using geviskon--novel in Russia alginate-containing drug--in treatment of acid-dependent diseases of the digestive system].
Tkachenko
E I
EI
Uspenskiĭ
Iu P
IuP
D000464:Alginates / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D004066:Digestive System Diseases / Q000188:drug therapy* / Q000378:metabolism; D004338:Drug Combinations; D005744:Gastric Acid / Q000378:metabolism*; D005765:Gastrointestinal Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D012824:Silicic Acid / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D017693:Sodium Bicarbonate / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
D000464:Alginates; D004338:Drug Combinations; D005765:Gastrointestinal Agents; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D017693:Sodium Bicarbonate